SONIC HEALTHCARE LIMITED (SHL)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

SHL - SONIC HEALTHCARE LIMITED

FNArena Sector : Healthcare services
Year End: June
GICS Industry Group : Health Care Equipment & Services
Index: ASX50 | ASX100 | ASX200 | ASX300 | ALL-ORDS

Sonic Healthcare is one of the world's largest medical diagnostics companies, providing laboratory and imaging services to medical practitioners, hospitals, community health services, and their collective patients. It was first listed in 1987.

LAST PRICE CHANGE +/- CHANGE % VOLUME

$30.42

08 Dec
2022

-0.420

OPEN

$30.94

-1.36%

HIGH

$31.12

1,178,948

LOW

$30.42

TARGET
$35.195 15.7% upside
Franking for last dividend paid out: 100%
OTHER COMPANIES IN THE SAME SECTOR
EBO . SLA . CAJ . GXL . HSO . MPL . MVF . NHF . HLS . RHC . VRT . MDR . M7T . HLA . PSQ . SIL . PKS . ONT . DOC . BMT . NVL . AHX . ALC . ACL .
FNARENA'S MARKET CONSENSUS FORECASTS
SHL: 1
Title FY21
Actual
FY22
Actual
FY23
Forecast
FY24
Forecast
EPS (cps) xxx 305.5 165.7 xxx
DPS (cps) xxx 100.0 100.9 xxx
EPS Growth xxx 10.9% - 45.8% xxx
DPS Growth xxx 9.9% 0.9% xxx
PE Ratio xxx N/A 18.2 xxx
Dividend Yield xxx N/A 3.3% xxx
Div Pay Ratio(%) xxx 32.7% 60.9% xxx

Dividend yield today if purchased 3 years ago: 3.40%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

3.31

Estimated Dividend Growth
(Average Of Past Three Years)

 %

Amount Invested

Tell Me The Dividend After This Many Years

Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 06/09 - ex-div 60c (franking 100%)

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2022 FactSet UK Limited. All rights reserved
Title 201720182019202020212022
EPS Basic xxxxxxxxxxxxxxx305.5
DPS All xxxxxxxxxxxxxxx100.0
Sales/Revenue xxxxxxxxxxxxxxx9,306.5 M
Book Value Per Share xxxxxxxxxxxxxxx1,542.1
Net Operating Cash Flow xxxxxxxxxxxxxxx2,225.8 M
Net Profit Margin xxxxxxxxxxxxxxx15.69 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 201720182019202020212022
Return on Capital Employed xxxxxxxxxxxxxxx21.39 %
Return on Invested Capital xxxxxxxxxxxxxxx15.36 %
Return on Assets xxxxxxxxxxxxxxx11.51 %
Return on Equity xxxxxxxxxxxxxxx21.39 %
Return on Total Capital xxxxxxxxxxxxxxx21.20 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx1,483.5 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

This is work in progress. Bear with us. It'll be amazing.

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.2

No. Of Recommendations

6
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Ord Minnett

xx/xx/xxxx

3

xxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Morgan Stanley

xx/xx/xxxx

1

xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Morgans

xx/xx/xxxx

3

xxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Macquarie

18/11/2022

5

Underperform

$31.30

2.89%

Covid testing was always expected to ease for Sonic Healthcare but yesterday's trading update indicated the drop-off is more rapid than Macquarie had forecast. At the same time, there remains the risk of cost inflation.

Macquarie's earnings forecasts are below consensus and a sum-of-the-parts valuation highlights downside risk at current levels, the broker notes.

Underperform retained, target falls to $31.30 from $31.50.

FORECAST
Macquarie forecasts a full year FY23 dividend of 103.00 cents and EPS of 156.00 cents.
Macquarie forecasts a full year FY24 dividend of 106.00 cents and EPS of 142.00 cents.

Citi

xx/xx/xxxx

3

xxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Credit Suisse

xx/xx/xxxx

1

xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

SHL STOCK CHART